Jeffrey Gendzwill is a registered patent attorney who concentrates his practice on patent-related matters with a focus on client counseling, portfolio strategy and management, US and foreign patent preparation/prosecution, post grant proceedings and enforcement. Mr. Gendzwill’s practice spans a wide range of technologies with a focus on the chemical and life sciences industry including chemical engineering, chemistry, clean energy and nutritional/pharmaceutical supplements, as well as mechanical and biomechanical engineering, nanotechnology, physics, composite materials and medical devices. Mr. Gendzwill also has extensive experience preparing complex patentability, invalidity, non-infringement, and freedom-to-operate opinions, as well as state-of-the-art analyses.
Prior to joining the firm, Mr. Gendzwill was a shareholder in a Virginia IP boutique firm where his areas of practice included client counseling, portfolio management, opinions, licensing and patent preparation/prosecution. Before that, Mr. Gendzwill was an associate at both a Washington, D.C. office of a large Chicago-based firm and at a mid-sized firm in metro-Detroit, where he handled patent portfolios for automotive manufacturers and component suppliers. Prior to launching his legal career, Mr. Gendzwill worked in the automotive industry as a chemical engineer and as a technical sales engineer for several Fortune 500 companies including 3M Company and Henkel International.
Mr. Gendzwill is a frequent speaker on many IP law issues including post-Alice Corp. patent eligibility and joint infringement jurisprudence.
Counsel for patentee Celanese in five inter partes review petitions filed by competitor Daicel challenging validity of Celanese patents related to industrial acetic acid production. The Patent Trial and Appeal Board initially ruled in favor of client Celanese, completely denying all five petitions, although requests for rehearing subsequently resulted in the institution of 3 of the 5 IPRs. In June of 2016, the PTAB issued final written decisions in the three IPRs, finding for patent owner Celanese and affirming all instituted claims as not unpatentable.
United States Patent and Trademark Office Patent Trial and Appeal Board, Case Numbers IPR2014-01514, IPR2014-01515, IPR2015-000170, IPR2015-00171 and IPR2015-00173.
University of Detroit Mercy School of Law, J.D. (2004) magna cum laude
University of Michigan, B.S., Chemical Engineering (1993)
District of Columbia (2008)
U.S. Patent and Trademark Office (2004)
U.S. District Court for the Eastern District of Michigan (2014)
Kilpatrick Townsend & Stockton D.C. Veterans Initiative, Steering Committee, Member
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.